Medical Devices Investors & VC Firms in United States

1104 firms in this list, with a median first check of $500K. 275 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
OM OMX Ventures CADFNHFS10 people · Follows rounds	88🔒	Lincolnshire	US	Seed–Series A	—	+ Add to CRM
HE Health2047 LKGMJSJB17 people	88🔒	San Francisco	US	Seed	—	+ Add to CRM
JL JLS LHSSJSBH14 people	88🔒	New York	US	Seed–Series B	—	+ Add to CRM
FR FREEFLOW DFSRFWBW10 people · Follows rounds	88🔒	Pasadena	US	Pre-Seed–Seed	—	+ Add to CRM
GL Global Blockchain Ventures AWDMDKMH12 people	88🔒	Orlando	US	Series A	—	+ Add to CRM
EX Excel Venture Management JETBCWSG7 people	88🔒	Boston	US	Series A–Late Stage	$1M – $5M	+ Add to CRM
BO Boomerang Ventures OMABDHEB9 people	88🔒	Indianapolis	US	Seed–Growth	$250K – $1.5M	+ Add to CRM
MA Martlet Capital IITHAWIG6 people	88🔒	Cambridge	GB	Pre-Seed–Series A	$317.5K	+ Add to CRM
BI Birchmere Ventures NRSASSMF5 people	88🔒	Pittsburgh	US	Seed–Series A	$500K – $5M	+ Add to CRM
EQ Equitage Ventures, L.L.C. AKMFRHDS10 people	88🔒	Denver	US	Pre-Seed–Series A	$250K – $2.5M	+ Add to CRM
IN InFocus Capital Partners, LLC RRRWGMRL19 people	88🔒	Jericho	US	Seed–Series A	—	+ Add to CRM
OH Ohio Innovation Fund BBFVMHMT7 people	88🔒	Dublin	US	Pre-Seed–Series A	$500K – $4M	+ Add to CRM
TI Time BioVentures DWTWTWBC15 people · Leads rounds	88🔒	Southern California	US	Seed–Series C	—	+ Add to CRM
IA IA Global AANIAGAG14 people · Leads rounds	88🔒	Austin	US	Pre-Seed–Seed	$500K – $1M	+ Add to CRM
QU quadraScope Venture Fund FMDFFWLC17 people	88🔒	Boston	US	—	—	+ Add to CRM
CU CU Healthcare Innovation Fund KMSLGBFL7 people	88🔒	Aurora	US	Seed–Series A	—	+ Add to CRM
AP APERTURE Venture Partners TNEHPTTP4 people	88🔒	New York	US	Seed–Series C	$1M – $5M	+ Add to CRM
CR Cressey & Company BCDRPDPE18 people	88🔒	Chicago	US	Growth	—	+ Add to CRM
MA Magnetic Ventures CAJSUEIP9 people · Leads rounds	88🔒	Boston	US	Seed–Series A	$1M – $6M	+ Add to CRM
3E 3E Bioventures Capital FYFFKLMY5 people · Follows rounds	88🔒	Palo Alto	US	Seed–Series A	—	+ Add to CRM
DC DC Investment Partners DDJA10 people	88🔒	McLean	US	Seed–Growth	$10M	+ Add to CRM
RA Raisewell Ventures JKJLASPJ19 people	88🔒	San Francisco Bay Area	US	Pre-Seed–Series B	—	+ Add to CRM
VS VSC Ventures JKMWVCAS11 people	88🔒	San Francisco	US	Pre-Seed–Seed	$500K – $750K	+ Add to CRM
FO Foreground Capital EBAPESJB9 people · Leads rounds	88🔒	Boston	US	Seed–Series B	—	+ Add to CRM

OMX Ventures

LincolnshireSeed–Series A

CADFNHFS10 people

Health2047

San FranciscoSeed

LKGMJSJB17 people

JLS

New YorkSeed–Series B

LHSSJSBH14 people

FREEFLOW

PasadenaPre-Seed–Seed

DFSRFWBW10 people

Global Blockchain Ventures

OrlandoSeries A

AWDMDKMH12 people

Excel Venture Management

BostonSeries A–Late Stage$1M – $5M

JETBCWSG7 people

Boomerang Ventures

IndianapolisSeed–Growth$250K – $1.5M

OMABDHEB9 people

Martlet Capital

CambridgePre-Seed–Series A$317.5K

IITHAWIG6 people

Birchmere Ventures

PittsburghSeed–Series A$500K – $5M

NRSASSMF5 people

Equitage Ventures, L.L.C.

DenverPre-Seed–Series A$250K – $2.5M

AKMFRHDS10 people

InFocus Capital Partners, LLC

JerichoSeed–Series A

RRRWGMRL19 people

Ohio Innovation Fund

DublinPre-Seed–Series A$500K – $4M

BBFVMHMT7 people

Time BioVentures

Southern CaliforniaSeed–Series C

DWTWTWBC15 people

IA Global

AustinPre-Seed–Seed$500K – $1M

AANIAGAG14 people

quadraScope Venture Fund

Boston

FMDFFWLC17 people

CU Healthcare Innovation Fund

AuroraSeed–Series A

KMSLGBFL7 people

APERTURE Venture Partners

New YorkSeed–Series C$1M – $5M

TNEHPTTP4 people

Cressey & Company

ChicagoGrowth

BCDRPDPE18 people

Magnetic Ventures

BostonSeed–Series A$1M – $6M

CAJSUEIP9 people

3E Bioventures Capital

Palo AltoSeed–Series A

FYFFKLMY5 people

DC Investment Partners

McLeanSeed–Growth$10M

DDJA10 people

Raisewell Ventures

San Francisco Bay AreaPre-Seed–Series B

JKJLASPJ19 people

VSC Ventures

San FranciscoPre-Seed–Seed$500K – $750K

JKMWVCAS11 people

Foreground Capital

BostonSeed–Series B

EBAPESJB9 people

Data sourced from public filings and firms' own websites — see our methodology.